Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management

Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Meri Tarockoff, MD

Date of Release

May 14th, 2025